Gena Wang analyst BARCLAYS

Currently, out of the existing stock ratings of Gena Wang - 175 which are a Buy (62.72%), 76 which are a Hold (27.24%), 28 which are a Sell (10.04%)

Gena Wang

Work Performance Price Targets & Ratings Chart

Analyst Gena Wang works at BARCLAYS and is covering Healthcare, Energy sectors with 541 price targets and ratings displayed on 41 stocks. Previously, Gena Wang worked at JEFFERIES.

Gena Wang's average stock forecast success ratio is 61.77% with an average time for price targets to be met of 167.15 days.

Most recent stock forecast was given on PTCT, PTC Therapeutics at 18-Sep-2023.

Wall Street Analyst Gena Wang

Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 12/29/2020. The price target of $46 was fulfilled within 1 day with a profit of $3.64 (8.59%) receiving and performance score of 85.93.

Average potential price target upside

ALNY Alnylam Pharmaceuticals ARCT Arcturus Therapeutics Holdings AVRO AVROBIO BCRX BioCryst Pharmaceuticals BEAM Beam Therapeutics BLUE bluebird bio CLVS Clovis Oncology CRSP CRISPR Therapeutics AG DBTX EDIT Editas Medicine IONS Ionis Pharmaceuticals KOD Kodiak Sciences LOGC LogicBio Therapeutics NTLA Intellia Therapeutics PBYI Puma Biotechnology PGNX PTCT PTC Therapeutics RARE Ultragenyx Pharmaceutical RGNX REGENXBIO SGEN Seattle Genetics SGMO Sangamo Therapeutics SGTX Sigilon Therapeutics SLDB Solid Biosciences SRPT Sarepta Therapeutics VIR Vir Biotechnology BMRN BioMarin Pharmaceutical ONCE VRTX Vertex Pharmaceuticals CLLS Cellectis MGTX MRNA Moderna ORTX Orchard Therapeutics plc ZYME Zymeworks IDRA Idera Pharmaceuticals LEGN ABEO Abeona Therapeutics DTIL HALO Halozyme Therapeutics MRTX Mirati Therapeutics RTRX SUN Sunoco LP

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

405

$229.48 (130.74%)

405

3 days ago

1/11 (9.09%)

$187.04 (111.43%)

664

Buy

240

$64.48 (36.74%)

247

7 days ago

18/21 (85.71%)

$25.52 (27.24%)

430

Buy

240

$64.48 (36.74%)

240

7 days ago

7/11 (63.64%)

$25.57 (14.48%)

233

Buy

270

$94.48 (53.83%)

270

9 days ago

3/10 (30%)

$52.1 (27.25%)

119

Buy

250

$74.48 (42.43%)

250

1 months 13 days ago

9/12 (75%)

$45.83 (47.46%)

396

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Gena Wang is most bullish on?

Potential upside of $56.01 has been obtained for NTLA (INTELLIA THERAPEUTICS)

Which stock is Gena Wang is most reserved on?

Potential downside of -$0.09 has been obtained for KOD (KODIAK SCIENCES)

What Year was the first public recommendation made by Gena Wang?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart